Epidemiology — MCQs

Epidemiology Indian Medical PG Practice Questions and MCQs

Question 1381: Which of the following diseases have a carrier stage?

A. Poliomyelitis
B. Cholera (Correct Answer)
C. Pertussis
D. Plague

Explanation: **Explanation:** The concept of a **carrier** is a person who harbors a specific infectious agent without having clinical disease but serves as a potential source of infection. **1. Why Cholera is Correct:** Cholera is a classic example of a disease with a carrier state. Carriers are categorized into: * **Incubatory:** Shedding the vibrio before symptoms appear. * **Convalescent:** Shedding for 2–3 weeks after recovery. * **Chronic:** Shedding for months or years (often harboring the bacteria in the gallbladder). In Cholera, the ratio of cases to carriers is approximately **1:10 for El Tor** and **1:100 for Classical** biotypes, making carriers the major "reservoir" for maintaining the infection in the community. **2. Why the other options are incorrect:** * **Poliomyelitis:** While polio has "inapparent infections" (silent cases), it does **not** have a chronic carrier state. The virus is excreted for only a few weeks. * **Pertussis (Whooping Cough):** There is **no carrier state** in Pertussis. The infection is maintained in the community solely by clinical or subclinical cases. * **Plague:** Plague is a zoonotic disease. Humans are "accidental hosts" and do not act as carriers. The reservoir is primarily wild rodents. **High-Yield Clinical Pearls for NEET-PG:** * **Diseases with NO carrier state:** Pertussis, Measles, Mumps, Smallpox, and Rubella. * **Chronic Carrier Examples:** Typhoid (Gallbladder), Hepatitis B, HIV, and Gonorrhea. * **The "Iceberg Phenomenon":** Cholera and Polio both show this, where carriers/subclinical cases form the submerged portion, but only Cholera is officially classified as having a distinct chronic carrier state in standard epidemiological texts.

Question 1382: Which vaccine requires the most stringent conditions for storage?

A. DPT
B. OPV (Correct Answer)
C. BCG
D. TT

Explanation: **Explanation:** The correct answer is **OPV (Oral Polio Vaccine)**. This is because OPV is the **most heat-sensitive vaccine** in the entire immunization schedule. It requires the most stringent storage conditions to maintain its potency, specifically needing long-term storage at **-20°C** (deep freezer) and short-term storage at **+2°C to +8°C**. **Why the other options are incorrect:** * **DPT and TT:** These are **heat-stable** but **freeze-sensitive** vaccines. They must be stored in the Cold Chain at +2°C to +8°C. If frozen, the aluminum adjuvant precipitates, destroying the vaccine's efficacy (confirmed by the "Shake Test"). * **BCG:** While BCG is heat-sensitive, it is more stable than OPV in its lyophilized (freeze-dried) form. However, once reconstituted, it becomes highly unstable and must be discarded within 4 hours. **High-Yield NEET-PG Pearls:** 1. **Heat Sensitivity Hierarchy:** (Most Sensitive) **OPV** > Measles/MR > BCG > DPT > DT > **TT** (Least Sensitive/Most Heat Stable). 2. **Freeze Sensitivity Hierarchy:** (Most Sensitive) **Hepatitis B** > DPT > TT. 3. **VVM (Vaccine Vial Monitor):** This is a heat-sensitive label found on vaccine vials (most crucially OPV) to indicate if the vaccine has been exposed to excessive heat over time. 4. **Storage Levels:** At the District level, OPV is kept in Deep Freezers (-20°C). At PHCs and Sub-centers, it is stored in the ILR (Ice-Lined Refrigerator) at +2°C to +8°C.

Question 1383: What is the time period between the entry of an organism into the body and the onset of maximum infectivity?

A. Lead time
B. Median incubation period
C. Generation time (Correct Answer)
D. Serial interval

Explanation: ### Explanation **1. Why "Generation Time" is Correct:** In epidemiology, **Generation Time** is defined as the interval between the entry of an infectious agent into a host and the time of **maximum infectivity** of that host. It represents the physiological equivalent of the "incubation period" but focuses on the transmission potential rather than clinical symptoms. For many diseases (like Mumps or Pertussis), a person is most infectious *before* symptoms appear; thus, tracking generation time is crucial for controlling the spread of an epidemic. **2. Why Other Options are Incorrect:** * **Lead Time (A):** This is the period between early detection of a disease (usually by screening) and the time of its usual clinical diagnosis. It is a concept used in screening programs, not transmission dynamics. * **Median Incubation Period (B):** The incubation period is the time from the entry of the organism to the **onset of clinical signs/symptoms**. The "median" is simply the middle value of this range in a population. * **Serial Interval (C):** This is the time gap between the onset of the primary case and the onset of the secondary case. While generation time is often estimated using the serial interval, they are not identical; serial interval is based on observable symptoms, whereas generation time is based on biological infectivity. **3. NEET-PG High-Yield Pearls:** * **Generation Time vs. Incubation Period:** If Generation Time is shorter than the Incubation Period, the disease is harder to control because individuals spread the infection before they know they are sick (e.g., HIV, Hepatitis A). * **Serial Interval:** In a stable epidemic, if the serial interval is short, the disease spreads rapidly. * **Formula:** In many practical scenarios, the Serial Interval is used as a proxy for Generation Time.

Question 1384: Which point in the natural history of disease marks the onset of symptoms?

A. A
B. B
C. C (Correct Answer)
D. D

Explanation: ### Explanation The **Natural History of Disease** describes the progression of a disease process in an individual over time, in the absence of treatment or intervention. It is divided into two main phases: the **Pre-pathogenesis phase** (interaction of agent, host, and environment) and the **Pathogenesis phase** (entry of the organism into the host). #### Why Option C is Correct: In the standard diagram of the natural history of disease: * **Point C** represents the **Clinical Stage**. This is the specific point where the disease process has progressed enough to produce recognizable signs and symptoms. It marks the transition from the "subclinical" or "latent" stage to the "clinical" stage. #### Analysis of Incorrect Options: * **Option A (Point A):** Represents the **Pre-pathogenesis phase**. Here, the disease has not yet started in the individual, but the factors (Agent-Host-Environment) are interacting to create a risk. * **Option B (Point B):** Represents the **Biological onset of disease**. This is when the agent first enters the host and starts pathological changes. It is the beginning of the **Incubation Period** (in infectious diseases) or the **Induction Period** (in non-communicable diseases). The patient is asymptomatic at this stage. * **Option D (Point D):** Represents the **Outcome**. This is the final stage where the disease results in recovery, disability, chronic state, or death. #### High-Yield Clinical Pearls for NEET-PG: * **Screening:** Usually takes place between Point B and Point C (the **Lead Time**). This is the "Subclinical phase" where the disease is detectable by tests but symptoms are absent. * **Iceberg Phenomenon:** The "Symptomatic" cases (Point C onwards) represent the **tip of the iceberg** (what the clinician sees), while the "Subclinical/Undiagnosed" cases (between B and C) represent the **submerged portion** (what the epidemiologist seeks). * **Incubation Period:** The time interval between Point B (exposure/entry) and Point C (onset of symptoms).

Question 1385: Which of the following statements regarding prevalence is true?

A. Prevalence cannot be used to determine the health needs of a community.
B. Prevalence is independent of incidence.
C. Prevalence is independent of duration.
D. Prevalence measures all existing cases of a condition. (Correct Answer)

Explanation: **Explanation** **1. Why the correct answer is right:** Prevalence is a measure of the total burden of a disease in a population at a specific point or period in time. Unlike incidence, which focuses only on new cases, prevalence accounts for **all existing cases** (both old and new). It provides a "snapshot" of the disease status, making it the primary indicator for assessing the magnitude of a health problem in a community. **2. Why the incorrect options are wrong:** * **Option A:** Prevalence is actually the **best measure** to determine the health needs of a community. It helps administrators plan for hospital beds, manpower, and resource allocation based on the total number of people currently requiring care. * **Option B & C:** Prevalence is mathematically dependent on both incidence and duration. The relationship is expressed by the formula: **P = I × D** (Prevalence = Incidence × Mean Duration). If a disease occurs more frequently (high incidence) or lasts longer (long duration/chronic), the prevalence will increase. **3. NEET-PG High-Yield Pearls:** * **Incidence vs. Prevalence:** Incidence is for **etiology/causation** (new cases); Prevalence is for **administrative planning** (total cases). * **The "Prevalence Pool":** New cases (Incidence) flow into the pool; deaths and cures flow out. * **Impact of Treatment:** If a new drug improves survival but does not cure the disease (e.g., Insulin for Diabetes or ART for HIV), the **prevalence increases** because the duration of the disease (D) increases. * **Point Prevalence:** Cases at a specific point in time (e.g., Jan 1st). * **Period Prevalence:** Cases existing during a defined period (e.g., an entire year).

Question 1386: If the prevalence of a disease is very low compared to its incidence, what does this imply?

A. The disease is very fatal and/or easily curable. (Correct Answer)
B. The disease is nonfatal.
C. The calculation of prevalence and incidence is incorrect.
D. Nothing can be said, as prevalence and incidence are independent.

Explanation: ### Explanation The relationship between prevalence (P) and incidence (I) is defined by the formula: **P = I × D**, where **D** represents the average duration of the disease. **Why Option A is Correct:** Prevalence represents the total number of existing cases (old + new) in a population at a given time. If prevalence is significantly lower than incidence, it means the **duration (D) of the disease is very short**. A short duration occurs under two clinical scenarios: 1. **High Fatality:** The patients die quickly after diagnosis (e.g., Rabies, Ebola). 2. **Rapid Recovery:** The patients are cured quickly (e.g., Common cold, Streptococcal pharyngitis). In both cases, the individuals leave the "prevalence pool" rapidly, keeping the prevalence low despite a high number of new cases (incidence). **Why Other Options are Incorrect:** * **Option B:** If a disease is nonfatal and chronic (e.g., Diabetes, Hypertension), the duration is long, which would make the prevalence much *higher* than the incidence. * **Option C:** This is a logical relationship based on epidemiological principles, not a calculation error. * **Option D:** Prevalence and incidence are mathematically linked by duration; they are not independent. **High-Yield Clinical Pearls for NEET-PG:** * **Incidence:** Measures the rate of occurrence of **new cases**. It is the best indicator for the **etiology** of a disease and the efficacy of prevention programs. * **Prevalence:** Measures the **burden** of a disease. It is most useful for administrative purposes and planning health services. * **Rule of Thumb:** If a new treatment is discovered that prevents death but does not cure the disease (e.g., Insulin for Diabetes), the **prevalence will increase** because the duration of the disease increases.

Question 1387: What is the best method to remove confounding?

A. Randomization
B. Restriction
C. Stratified randomization (Correct Answer)
D. Multivariate analysis

Explanation: ### Explanation Confounding occurs when an extraneous variable is associated with both the exposure and the outcome, potentially distorting the true relationship. While several methods exist to address this, **Stratified Randomization** is considered the superior method because it combines the strengths of two techniques: **Randomization** and **Stratification**. **Why Stratified Randomization is the best:** In standard randomization, there is still a chance of "accidental bias" where confounders are distributed unequally between groups, especially in small samples. Stratified randomization first groups (stratifies) subjects based on the known confounder (e.g., age or smoking status) and *then* randomizes them within those strata. This ensures an **absolute balance** of the confounding factor across study groups at the design stage, providing more statistical power than simple randomization. **Analysis of Incorrect Options:** * **A. Randomization:** While it is the "heart" of a clinical trial and controls for both known and *unknown* confounders, it does not guarantee balance for specific known confounders in smaller sample sizes. * **B. Restriction:** This involves limiting the study to a specific group (e.g., only non-smokers). While it eliminates the confounder, it severely limits the **generalizability** (external validity) of the study and reduces the sample size. * **D. Multivariate Analysis:** This is a method to control confounding at the **analysis stage** (after data collection). While useful, it is mathematically complex and cannot account for unknown confounders as effectively as design-stage methods. **High-Yield Pearls for NEET-PG:** * **Design Stage methods:** Randomization, Restriction, and Matching. * **Analysis Stage methods:** Stratification and Statistical Modeling (Multivariate analysis). * **Randomization** is the only method that controls for **unknown/unmeasured** confounders. * **Matching** is most commonly used in Case-Control studies but carries the risk of "over-matching."

Question 1388: In a study, 30 out of 50 smokers developed lung cancer, and 10 out of 50 non-smokers developed lung cancer. What is the odds ratio?

A. 4
B. 2.8
C. 6 (Correct Answer)
D. 7

Explanation: ### Explanation **1. Why the Correct Answer (C) is Right** The **Odds Ratio (OR)** is a measure of association used primarily in case-control studies to quantify the relationship between an exposure and an outcome. It is calculated as the ratio of the odds of exposure in cases to the odds of exposure in controls, or more simply, using a 2x2 contingency table: | | Disease (+) | Disease (-) | Total | | :--- | :---: | :---: | :---: | | **Exposed (Smokers)** | 30 (a) | 20 (b) | 50 | | **Non-exposed (Non-smokers)** | 10 (c) | 40 (d) | 50 | * **a (Exposed cases):** 30 * **b (Exposed non-cases):** 50 - 30 = 20 * **c (Non-exposed cases):** 10 * **d (Non-exposed non-cases):** 50 - 10 = 40 **Formula:** $OR = \frac{a \times d}{b \times c}$ **Calculation:** $OR = \frac{30 \times 40}{20 \times 10} = \frac{1200}{200} = \mathbf{6}$ An OR of 6 indicates that the odds of developing lung cancer are 6 times higher in smokers compared to non-smokers. **2. Why Other Options are Wrong** * **Option A (4):** This is a common distractor if a student incorrectly calculates the ratio of diseased individuals (30/10) or makes a calculation error. * **Option B (2.8):** This value is close to the **Relative Risk (RR)**. $RR = \frac{\text{Incidence in exposed}}{\text{Incidence in non-exposed}} = \frac{30/50}{10/50} = \frac{0.6}{0.2} = 3$. * **Option D (7):** Incorrect calculation; does not correspond to any standard epidemiological measure for this data. **3. NEET-PG Clinical Pearls** * **Odds Ratio** is the only measure of association that can be calculated in **Case-Control studies**. * **Relative Risk (RR)** is calculated in **Cohort studies**. * When a disease is rare, the OR is a good approximation of the RR. * **Attributable Risk (AR):** Indicates the amount of disease that can be prevented by removing the exposure. $AR = \frac{I_e - I_u}{I_e} \times 100$.

Question 1389: Which of the following is true regarding case-control studies?

A. It proceeds from effect to cause.
B. The odds ratio can be calculated. (Correct Answer)
C. Incidence can be calculated.
D. It requires a large number of patients.

Explanation: In epidemiology, a **Case-Control Study** is an observational, analytical study used to identify the association between an exposure and an outcome. ### Why the Correct Answer is Right **Option B (Odds Ratio):** Since case-control studies start with people who already have the disease (cases), we cannot determine the actual risk of developing the disease. Instead, we calculate the **Odds Ratio (OR)**, which is the ratio of the odds of exposure among cases to the odds of exposure among controls. It serves as an estimate of the relative risk. ### Why Other Options are Wrong * **Option A:** This is partially true but technically described as **retrospective**. While it looks backward from effect (disease) to cause (exposure), the standard epidemiological phrasing is that it is "retrospective" in nature. However, Option B is the definitive statistical hallmark of this study design. * **Option C:** **Incidence cannot be calculated** in case-control studies because the denominator (population at risk) is unknown. Incidence can only be calculated in **Cohort Studies**. * **Option D:** Case-control studies are ideal for **rare diseases** and typically require a **smaller sample size** compared to cohort studies, making them inexpensive and quick to conduct. ### High-Yield NEET-PG Pearls * **Direction:** Backward (Effect $\rightarrow$ Cause). * **Measure of Association:** Odds Ratio ($ad/bc$). * **Best for:** Rare diseases or diseases with long latency periods (e.g., Cancer). * **Main Bias:** **Recall Bias** (cases remember past exposures more vividly than controls). * **Matching:** Done to eliminate the effects of **confounding variables**.

Question 1390: Which study design is used to correlate genetic diseases with consanguinity?

A. Case-control study (Correct Answer)
B. Cohort study
C. Cross-sectional study
D. Case report

Explanation: ### Explanation **Why Case-control study is correct:** Genetic diseases, particularly those linked to consanguinity (autosomal recessive disorders), are typically **rare** in the general population. The **Case-control study** is the design of choice for studying rare diseases. In this design, researchers start with "Cases" (children with the genetic disease) and "Controls" (healthy children) and look backward (**retrospective**) to determine the frequency of the exposure (consanguineous marriage among parents). It is time-efficient and cost-effective for conditions with long latency or low prevalence. **Why the other options are incorrect:** * **Cohort study:** This starts with the exposure (consanguinity) and follows the group forward to see if the disease develops. Because these genetic diseases are rare, a massive sample size and decades of follow-up would be required, making it impractical and expensive. * **Cross-sectional study:** This measures prevalence at a single point in time. While it can show an association, it is weak at establishing a causal link for rare genetic conditions compared to the case-control method. * **Case report:** This describes a single patient’s clinical features. While it may suggest an association, it lacks a comparison group and cannot be used to scientifically correlate or prove an epidemiological link. **High-Yield Clinical Pearls for NEET-PG:** * **Study of Choice for Rare Diseases:** Case-control study. * **Study of Choice for Rare Exposures:** Cohort study (e.g., a specific chemical leak). * **Measure of Association:** Case-control uses **Odds Ratio (OR)**; Cohort uses **Relative Risk (RR)**. * **Consanguinity Risk:** Increases the risk of **Autosomal Recessive** conditions due to increased homozygosity (sharing of common alleles from a common ancestor).

Practice by Chapter

Principles of Epidemiology

Practice Questions

Measures of Disease Frequency

Practice Questions

Epidemiological Study Designs

Practice Questions

Descriptive Epidemiology

Practice Questions

Analytical Epidemiology

Practice Questions

Experimental Epidemiology

Practice Questions

Screening for Disease

Practice Questions

Surveillance Systems

Practice Questions

Investigation of an Epidemic

Practice Questions

Association and Causation

Practice Questions

Modern Epidemiological Methods

Practice Questions

Critical Appraisal of Epidemiological Studies

Practice Questions

Want unlimited practice?

Get full access to all questions, explanations, and performance tracking.

Start For Free